Robeco QI Global Developed Multi-Factor Equities

170,93
-0,77%
06/12/2022
Riesgo
5/7
ISIN
LU1277577125
Patrimonio
193,1M€
Rentabilidad YTD
-4,34%

Estrategia de inversión

The aim of the Sub-fund is to provide long term capital growth. The Sub-fund will take exposure of at least two-thirds of its total assets to equities of companies that mainly operate in mature economies (developed markets) all over the world. The Sub-fund focuses on offering exposure to multiple factors such as but not limited to value, low volatility, momentum and quality. The Sub-fund invests systematically in companies exposed to these factors in a diversified way.

Comisiones

Defer Load
0.00%
Front Load
5.00%
Management Fee
1.00%
On Going Charge
1.21%
Redemption Fee
0.00%
Total Expense Ratio
1.21%

Otras clases

Nombre ISIN Comisión
Robeco QI Global Developed Multi-Factor Equities I $ LU1277577638 0,55 %
Robeco QI Global Developed Multi-Factor Equities I € LU1277577398 0,55 %
Robeco QI Global Developed Multi-Factor Equities D € LU1277577125 1,00 %

Rentabilidad por períodos

Período
Acumulada
Anualizada
Año actual
-4,34% -
30 días
-0,62% -
6 meses
0,95% -
12 meses
-1,07% -
2 años
29,69% 13,88%
3 años
22,95% 7,13%
5 años
37,34% 6,55%

Rentabilidad por trimestres

Año T1 T2 T3 T4
2015 - - - - 7,87%
2016 10,91% -3,66% 3,65% 2,99% 7,85%
2017 6,99% 3,83% -3,16% 1,53% 4,80%
2018 -9,13% -3,48% 5,97% 3,80% -14,41%
2019 22,84% 13,91% -0,22% 3,71% 4,22%
2020 -4,59% -25,67% 15,21% 1,48% 9,78%
2021 33,93% 13,22% 6,06% 1,35% 10,04%
2022 - -2,79% -7,90% 0,78% -

Rentabilidad mensual

Rentabilidad de los últimos 12 meses

Cartera

#
Posición
Peso
Valor
1
Bristol-Myers Squibb Co
1,60%
3.016.172€
2
Apple Inc
1,34%
2.537.437€
3
Gilead Sciences Inc
1,28%
2.422.269€
4
McKesson Corp
1,21%
2.295.603€
5
Pfizer Inc
1,07%
2.016.437€
6
AutoZone Inc
0,97%
1.832.356€
7
AT&T Inc
0,96%
1.812.263€
8
Novo Nordisk A/S Class B
0,93%
1.756.571€
9
Equinor ASA
0,89%
1.675.383€
10
Costco Wholesale Corp
0,87%
1.649.634€

Principales 10 posiciones en cartera

Categoría

Top Robeco QI Global Developed Multi-Factor Equities frente a su categoría

Documentos

Documento
Última actualización
Prospectus
09/11/2022
Factsheet
26/11/2022
Factsheet Institutional
26/11/2022
SemiannualReport
24/11/2022
Key Investor Information Document (KIID)
20/02/2022
AnnualReport
24/11/2022
Rulebook
09/11/2022

Divisas

Materias primas

Volver arriba